Nanalysis Scientific (CVE:NSCI) Hits New 12-Month Low – What’s Next?

Shares of Nanalysis Scientific Corp. (CVE:NSCI) reached a new 52-week low during trading on Thursday . The company traded as low as C$0.15 and last traded at C$0.15, with a volume of 100005 shares. The stock had previously closed at C$0.15.

Nanalysis Scientific Stock Up 3.4%

The stock’s fifty day moving average price is C$0.16 and its 200 day moving average price is C$0.18. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72. The stock has a market cap of C$17.22 million, a P/E ratio of -1.50 and a beta of -0.88.

About Nanalysis Scientific

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.